Global Prostate Cancer Therapeutic Sales Market Report 2016

Publisher Name :
Date: 12-Sep-2016
No. of pages: 125
Inquire Before Buying

Notes:

Sales, means the sales volume of Prostate Cancer Therapeutic

Revenue, means the sales value of Prostate Cancer Therapeutic

This report studies sales (consumption) of Prostate Cancer Therapeutic in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

- Pfizer Inc. (USA)

- Abbott Laboratories (USA)

- Genentech Inc. (USA)

- GlaxoSmithKline Plc (UK)

- Immunomedics, Inc. (USA)

- Indevus Pharmaceuticals Inc. (USA)

- Novartis AG (Switzerland)

- OSI Pharmaceuticals, Inc. (USA)

- Paladin Labs Inc. (Canada)

- ALZA Corporation (USA)

- Amgen Inc. (USA)

- AstraZeneca PLC (UK)

- Medimmune, LLC (USA)

- Bristol-Myers Squibb Company (USA)

- Cell Genesys Inc. (USA)

- Dendreon Corporation (USA)

- EUSA Pharma, (USA) Inc. (USA)

- F. Hoffmann-La Roche Ltd. (Switzerland)

- Progenics Pharmaceuticals, Inc. (USA)

- Sanofi-Aventis SA (France)

- Spectrum Pharmaceuticals, Inc. (USA)

- Takeda Pharmaceutical Company Limited (Japan)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Prostate Cancer Therapeutic in these regions, from 2011 to 2021 (forecast), like

- USA

- China

- Europe

- Japan

- India

- Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Prostate Cancer Therapeutic in each application, can be divided into

- Application 1

- Application 2

- Application 3

Global Prostate Cancer Therapeutic Sales Market Report 2016

Table of Contents
Global Prostate Cancer Therapeutic Sales Market Report 2016
1 Prostate Cancer Therapeutic Overview
1.1 Product Overview and Scope of Prostate Cancer Therapeutic
1.2 Classification of Prostate Cancer Therapeutic
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Prostate Cancer Therapeutic
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Prostate Cancer Therapeutic Market by Regions
1.4.1 USA Status and Prospect (2011-2021)
1.4.2 China Status and Prospect (2011-2021)
1.4.3 Europe Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 India Status and Prospect (2011-2021)
1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Prostate Cancer Therapeutic (2011-2021)
1.5.1 Global Prostate Cancer Therapeutic Sales and Growth Rate (2011-2021)
1.5.2 Global Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)
2 Global Prostate Cancer Therapeutic Competition by Manufacturers, Type and Application
2.1 Global Prostate Cancer Therapeutic Market Competition by Manufacturers
2.1.1 Global Prostate Cancer Therapeutic Sales and Market Share of Key Manufacturers (2011-2016)
2.1.2 Global Prostate Cancer Therapeutic Revenue and Share by Manufacturers (2011-2016)
2.2 Global Prostate Cancer Therapeutic (Volume and Value) by Type
2.2.1 Global Prostate Cancer Therapeutic Sales and Market Share by Type (2011-2016)
2.2.2 Global Prostate Cancer Therapeutic Revenue and Market Share by Type (2011-2016)
2.3 Global Prostate Cancer Therapeutic (Volume and Value) by Regions
2.3.1 Global Prostate Cancer Therapeutic Sales and Market Share by Regions (2011-2016)
2.3.2 Global Prostate Cancer Therapeutic Revenue and Market Share by Regions (2011-2016)
2.4 Global Prostate Cancer Therapeutic (Volume) by Application
3 USA Prostate Cancer Therapeutic (Volume, Value and Sales Price)
3.1 USA Prostate Cancer Therapeutic Sales and Value (2011-2016)
3.1.1 USA Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)
3.1.2 USA Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)
3.1.3 USA Prostate Cancer Therapeutic Sales Price Trend (2011-2016)
3.2 USA Prostate Cancer Therapeutic Sales and Market Share by Manufacturers
3.3 USA Prostate Cancer Therapeutic Sales and Market Share by Type
3.4 USA Prostate Cancer Therapeutic Sales and Market Share by Application
4 China Prostate Cancer Therapeutic (Volume, Value and Sales Price)
4.1 China Prostate Cancer Therapeutic Sales and Value (2011-2016)
4.1.1 China Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)
4.1.2 China Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)
4.1.3 China Prostate Cancer Therapeutic Sales Price Trend (2011-2016)
4.2 China Prostate Cancer Therapeutic Sales and Market Share by Manufacturers
4.3 China Prostate Cancer Therapeutic Sales and Market Share by Type
4.4 China Prostate Cancer Therapeutic Sales and Market Share by Application
5 Europe Prostate Cancer Therapeutic (Volume, Value and Sales Price)
5.1 Europe Prostate Cancer Therapeutic Sales and Value (2011-2016)
5.1.1 Europe Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)
5.1.2 Europe Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)
5.1.3 Europe Prostate Cancer Therapeutic Sales Price Trend (2011-2016)
5.2 Europe Prostate Cancer Therapeutic Sales and Market Share by Manufacturers
5.3 Europe Prostate Cancer Therapeutic Sales and Market Share by Type
5.4 Europe Prostate Cancer Therapeutic Sales and Market Share by Application
6 Japan Prostate Cancer Therapeutic (Volume, Value and Sales Price)
6.1 Japan Prostate Cancer Therapeutic Sales and Value (2011-2016)
6.1.1 Japan Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)
6.1.2 Japan Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)
6.1.3 Japan Prostate Cancer Therapeutic Sales Price Trend (2011-2016)
6.2 Japan Prostate Cancer Therapeutic Sales and Market Share by Manufacturers
6.3 Japan Prostate Cancer Therapeutic Sales and Market Share by Type
6.4 Japan Prostate Cancer Therapeutic Sales and Market Share by Application
7 India Prostate Cancer Therapeutic (Volume, Value and Sales Price)
7.1 India Prostate Cancer Therapeutic Sales and Value (2011-2016)
7.1.1 India Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)
7.1.2 India Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)
7.1.3 India Prostate Cancer Therapeutic Sales Price Trend (2011-2016)
7.2 India Prostate Cancer Therapeutic Sales and Market Share by Manufacturers
7.3 India Prostate Cancer Therapeutic Sales and Market Share by Type
7.4 India Prostate Cancer Therapeutic Sales and Market Share by Application
8 Southeast Asia Prostate Cancer Therapeutic (Volume, Value and Sales Price)
8.1 Southeast Asia Prostate Cancer Therapeutic Sales and Value (2011-2016)
8.1.1 Southeast Asia Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)
8.1.2 Southeast Asia Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)
8.1.3 Southeast Asia Prostate Cancer Therapeutic Sales Price Trend (2011-2016)
8.2 Southeast Asia Prostate Cancer Therapeutic Sales and Market Share by Manufacturers
8.3 Southeast Asia Prostate Cancer Therapeutic Sales and Market Share by Type
8.4 Southeast Asia Prostate Cancer Therapeutic Sales and Market Share by Application
9 Global Prostate Cancer Therapeutic Manufacturers Analysis
9.1 Pfizer Inc. (USA)
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Prostate Cancer Therapeutic Product Type, Application and Specification
9.1.2.1 Type I
9.1.2.2 Type II
9.1.3 Pfizer Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
9.1.4 Main Business/Business Overview
9.2 Abbott Laboratories (USA)
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 125 Product Type, Application and Specification
9.2.2.1 Type I
9.2.2.2 Type II
9.2.3 Abbott Laboratories (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
9.2.4 Main Business/Business Overview
9.3 Genentech Inc. (USA)
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 147 Product Type, Application and Specification
9.3.2.1 Type I
9.3.2.2 Type II
9.3.3 Genentech Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline Plc (UK)
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Aug Product Type, Application and Specification
9.4.2.1 Type I
9.4.2.2 Type II
9.4.3 GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
9.4.4 Main Business/Business Overview
9.5 Immunomedics, Inc. (USA)
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Product Type, Application and Specification
9.5.2.1 Type I
9.5.2.2 Type II
9.5.3 Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
9.5.4 Main Business/Business Overview
9.6 Indevus Pharmaceuticals Inc. (USA)
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Million USD Product Type, Application and Specification
9.6.2.1 Type I
9.6.2.2 Type II
9.6.3 Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
9.6.4 Main Business/Business Overview
9.7 Novartis AG (Switzerland)
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Pharma & Healthcare Product Type, Application and Specification
9.7.2.1 Type I
9.7.2.2 Type II
9.7.3 Novartis AG (Switzerland) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
9.7.4 Main Business/Business Overview
9.8 OSI Pharmaceuticals, Inc. (USA)
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Product Type, Application and Specification
9.8.2.1 Type I
9.8.2.2 Type II
9.8.3 OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
9.8.4 Main Business/Business Overview
9.9 Paladin Labs Inc. (Canada)
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Product Type, Application and Specification
9.9.2.1 Type I
9.9.2.2 Type II
9.9.3 Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
9.9.4 Main Business/Business Overview
9.10 ALZA Corporation (USA)
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Product Type, Application and Specification
9.10.2.1 Type I
9.10.2.2 Type II
9.10.3 ALZA Corporation (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
9.10.4 Main Business/Business Overview
9.11 Amgen Inc. (USA)
9.12 AstraZeneca PLC (UK)
9.13 Medimmune, LLC (USA)
9.14 Bristol-Myers Squibb Company (USA)
9.15 Cell Genesys Inc. (USA)
9.16 Dendreon Corporation (USA)
9.17 EUSA Pharma, (USA) Inc. (USA)
9.18 F. Hoffmann-La Roche Ltd. (Switzerland)
9.19 Progenics Pharmaceuticals, Inc. (USA)
9.20 Sanofi-Aventis SA (France)
9.21 Spectrum Pharmaceuticals, Inc. (USA)
9.22 Takeda Pharmaceutical Company Limited (Japan)
10 Prostate Cancer Therapeutic Maufacturing Cost Analysis
10.1 Prostate Cancer Therapeutic Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Prostate Cancer Therapeutic
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Prostate Cancer Therapeutic Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Prostate Cancer Therapeutic Major Manufacturers in 2015
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Prostate Cancer Therapeutic Market Forecast (2016-2021)
14.1 Global Prostate Cancer Therapeutic Sales, Revenue Forecast (2016-2021)
14.2 Global Prostate Cancer Therapeutic Sales Forecast by Regions (2016-2021)
14.3 Global Prostate Cancer Therapeutic Sales Forecast by Type (2016-2021)
14.4 Global Prostate Cancer Therapeutic Sales Forecast by Application (2016-2021)
15 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Prostate Cancer Therapeutic
Table Classification of Prostate Cancer Therapeutic
Figure Global Sales Market Share of Prostate Cancer Therapeutic by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Prostate Cancer Therapeutic
Figure Global Sales Market Share of Prostate Cancer Therapeutic by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)
Figure China Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)
Figure Europe Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)
Figure Japan Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)
Figure India Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)
Figure Global Prostate Cancer Therapeutic Sales and Growth Rate (2011-2021)
Figure Global Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)
Table Global Prostate Cancer Therapeutic Sales of Key Manufacturers (2011-2016)
Table Global Prostate Cancer Therapeutic Sales Share by Manufacturers (2011-2016)
Figure 2015 Prostate Cancer Therapeutic Sales Share by Manufacturers
Figure 2016 Prostate Cancer Therapeutic Sales Share by Manufacturers
Table Global Prostate Cancer Therapeutic Revenue by Manufacturers (2011-2016)
Table Global Prostate Cancer Therapeutic Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Prostate Cancer Therapeutic Revenue Share by Manufacturers
Table 2016 Global Prostate Cancer Therapeutic Revenue Share by Manufacturers
Table Global Prostate Cancer Therapeutic Sales and Market Share by Type (2011-2016)
Table Global Prostate Cancer Therapeutic Sales Share by Type (2011-2016)
Figure Sales Market Share of Prostate Cancer Therapeutic by Type (2011-2016)
Figure Global Prostate Cancer Therapeutic Sales Growth Rate by Type (2011-2016)
Table Global Prostate Cancer Therapeutic Revenue and Market Share by Type (2011-2016)
Table Global Prostate Cancer Therapeutic Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Prostate Cancer Therapeutic by Type (2011-2016)
Figure Global Prostate Cancer Therapeutic Revenue Growth Rate by Type (2011-2016)
Table Global Prostate Cancer Therapeutic Sales and Market Share by Regions (2011-2016)
Table Global Prostate Cancer Therapeutic Sales Share by Regions (2011-2016)
Figure Sales Market Share of Prostate Cancer Therapeutic by Regions (2011-2016)
Figure Global Prostate Cancer Therapeutic Sales Growth Rate by Regions (2011-2016)
Table Global Prostate Cancer Therapeutic Revenue and Market Share by Regions (2011-2016)
Table Global Prostate Cancer Therapeutic Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Prostate Cancer Therapeutic by Regions (2011-2016)
Figure Global Prostate Cancer Therapeutic Revenue Growth Rate by Regions (2011-2016)
Table Global Prostate Cancer Therapeutic Sales and Market Share by Application (2011-2016)
Table Global Prostate Cancer Therapeutic Sales Share by Application (2011-2016)
Figure Sales Market Share of Prostate Cancer Therapeutic by Application (2011-2016)
Figure Global Prostate Cancer Therapeutic Sales Growth Rate by Application (2011-2016)
Figure USA Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)
Figure USA Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)
Figure USA Prostate Cancer Therapeutic Sales Price Trend (2011-2016)
Table USA Prostate Cancer Therapeutic Sales by Manufacturers (2011-2016)
Table USA Prostate Cancer Therapeutic Market Share by Manufacturers (2011-2016)
Table USA Prostate Cancer Therapeutic Sales by Type (2011-2016)
Table USA Prostate Cancer Therapeutic Market Share by Type (2011-2016)
Table USA Prostate Cancer Therapeutic Sales by Application (2011-2016)
Table USA Prostate Cancer Therapeutic Market Share by Application (2011-2016)
Figure China Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)
Figure China Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)
Figure China Prostate Cancer Therapeutic Sales Price Trend (2011-2016)
Table China Prostate Cancer Therapeutic Sales by Manufacturers (2011-2016)
Table China Prostate Cancer Therapeutic Market Share by Manufacturers (2011-2016)
Table China Prostate Cancer Therapeutic Sales by Type (2011-2016)
Table China Prostate Cancer Therapeutic Market Share by Type (2011-2016)
Table China Prostate Cancer Therapeutic Sales by Application (2011-2016)
Table China Prostate Cancer Therapeutic Market Share by Application (2011-2016)
Figure Europe Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)
Figure Europe Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)
Figure Europe Prostate Cancer Therapeutic Sales Price Trend (2011-2016)
Table Europe Prostate Cancer Therapeutic Sales by Manufacturers (2011-2016)
Table Europe Prostate Cancer Therapeutic Market Share by Manufacturers (2011-2016)
Table Europe Prostate Cancer Therapeutic Sales by Type (2011-2016)
Table Europe Prostate Cancer Therapeutic Market Share by Type (2011-2016)
Table Europe Prostate Cancer Therapeutic Sales by Application (2011-2016)
Table Europe Prostate Cancer Therapeutic Market Share by Application (2011-2016)
Figure Japan Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)
Figure Japan Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)
Figure Japan Prostate Cancer Therapeutic Sales Price Trend (2011-2016)
Table Japan Prostate Cancer Therapeutic Sales by Manufacturers (2011-2016)
Table Japan Prostate Cancer Therapeutic Market Share by Manufacturers (2011-2016)
Table Japan Prostate Cancer Therapeutic Sales by Type (2011-2016)
Table Japan Prostate Cancer Therapeutic Market Share by Type (2011-2016)
Table Japan Prostate Cancer Therapeutic Sales by Application (2011-2016)
Table Japan Prostate Cancer Therapeutic Market Share by Application (2011-2016)
Figure India Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)
Figure India Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)
Figure India Prostate Cancer Therapeutic Sales Price Trend (2011-2016)
Table India Prostate Cancer Therapeutic Sales by Manufacturers (2011-2016)
Table India Prostate Cancer Therapeutic Market Share by Manufacturers (2011-2016)
Table India Prostate Cancer Therapeutic Sales by Type (2011-2016)
Table India Prostate Cancer Therapeutic Market Share by Type (2011-2016)
Table India Prostate Cancer Therapeutic Sales by Application (2011-2016)
Table India Prostate Cancer Therapeutic Market Share by Application (2011-2016)
Figure Southeast Asia Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)
Figure Southeast Asia Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Prostate Cancer Therapeutic Sales Price Trend (2011-2016)
Table Southeast Asia Prostate Cancer Therapeutic Sales by Manufacturers (2011-2016)
Table Southeast Asia Prostate Cancer Therapeutic Market Share by Manufacturers (2011-2016)
Table Southeast Asia Prostate Cancer Therapeutic Sales by Type (2011-2016)
Table Southeast Asia Prostate Cancer Therapeutic Market Share by Type (2011-2016)
Table Southeast Asia Prostate Cancer Therapeutic Sales by Application (2011-2016)
Table Southeast Asia Prostate Cancer Therapeutic Market Share by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Genentech Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG (Switzerland) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information List
Table ALZA Corporation (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure ALZA Corporation (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Amgen Inc. (USA) Basic Information List
Table Amgen Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table AstraZeneca PLC (UK) Basic Information List
Table AstraZeneca PLC (UK) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca PLC (UK) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Medimmune, LLC (USA) Basic Information List
Table Medimmune, LLC (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Medimmune, LLC (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Bristol-Myers Squibb Company (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Company (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Cell Genesys Inc. (USA) Basic Information List
Table Cell Genesys Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Cell Genesys Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Dendreon Corporation (USA) Basic Information List
Table Dendreon Corporation (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon Corporation (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Basic Information List
Table EUSA Pharma, (USA) Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure EUSA Pharma, (USA) Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List
Table Progenics Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Progenics Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Sanofi-Aventis SA (France) Basic Information List
Table Sanofi-Aventis SA (France) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi-Aventis SA (France) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List
Table Spectrum Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Spectrum Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Pharmaceutical Company Limited (Japan) Prostate Cancer Therapeutic Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Therapeutic
Figure Manufacturing Process Analysis of Prostate Cancer Therapeutic
Figure Prostate Cancer Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Therapeutic Major Manufacturers in 2015
Table Major Buyers of Prostate Cancer Therapeutic
Table Distributors/Traders List
Figure Global Prostate Cancer Therapeutic Sales and Growth Rate Forecast (2016-2021)
Figure Global Prostate Cancer Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Table Global Prostate Cancer Therapeutic Sales Forecast by Regions (2016-2021)
Table Global Prostate Cancer Therapeutic Sales Forecast by Type (2016-2021)
Table Global Prostate Cancer Therapeutic Sales Forecast by Application (2016-2021)
  • 2017-2022 Philippines Vaginal Pessary Market Report (Status and Outlook)
    Published: 21-Jul-2017        Price: US 3360 Onwards        Pages: 111
    "This report will be delivered in 2-3 business days after the order is placed." The Vaginal Pessary market size will be XX million (USD) in 2022 in Philippines, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Malaysia market, the top players include CooperSurgical MedGyn Personal Medical Corp Integra LifeSciences Panpac ......
  • 2017-2022 United States Vaginal Pessary Market Report (Status and Outlook)
    Published: 21-Jul-2017        Price: US 3360 Onwards        Pages: 111
    "This report will be delivered in 2-3 business days after the order is placed." The Vaginal Pessary market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In United States market, the top players include CooperSurgical MedGyn Personal Medical Corp Integra LifeSciences ......
  • 2017 Top 5 Vaginal Pessary Manufacturers in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 21-Jul-2017        Price: US 4960 Onwards        Pages: 163
    "This report will be delivered in 2-3 business days after the order is placed." The Global Vaginal Pessary market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Vaginal Pessary in Global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Vaginal Pessary Players in each reg......
  • 2017-2022 China Vaginal Pessary Market Report (Status and Outlook)
    Published: 21-Jul-2017        Price: US 3360 Onwards        Pages: 111
    "This report will be delivered in 2-3 business days after the order is placed." The Vaginal Pessary market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include CooperSurgical MedGyn Personal Medical Corp Integra LifeSciences Panpac Medical......
  • 2017-2022 Global Top Countries Vaginal Pessary Market Report
    Published: 21-Jul-2017        Price: US 4960 Onwards        Pages: 163
    "This report will be delivered in 2-3 business days after the order is placed." The Global Vaginal Pessary market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. This report studies Vaginal Pessary in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Mi......
  • 2017-2022 India Vaginal Pessary Market Report (Status and Outlook)
    Published: 21-Jul-2017        Price: US 3360 Onwards        Pages: 111
    "This report will be delivered in 2-3 business days after the order is placed." The Vaginal Pessary market size will be XX million (USD) in 2022 in India, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In India market, the top players include CooperSurgical MedGyn Personal Medical Corp Integra LifeSciences Panpac Medical......
  • 2017-2022 Japan Vaginal Pessary Market Report (Status and Outlook)
    Published: 21-Jul-2017        Price: US 3360 Onwards        Pages: 111
    "This report will be delivered in 2-3 business days after the order is placed." The Vaginal Pessary market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Japan market, the top players include CooperSurgical MedGyn Personal Medical Corp Integra LifeSciences Panpac Medical......
  • 2017-2022 Malaysia Vaginal Pessary Market Report (Status and Outlook)
    Published: 21-Jul-2017        Price: US 3360 Onwards        Pages: 111
    "This report will be delivered in 2-3 business days after the order is placed." The Vaginal Pessary market size will be XX million (USD) in 2022 in Malaysia, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In Malaysia market, the top players include CooperSurgical MedGyn Personal Medical Corp Integra LifeSciences Panpac Med......
  • EMEA (Europe, Middle East and Africa) Para-menthane-3,8-diol (PMD) Market Report 2017
    Published: 20-Jul-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the EMEA Para-menthane-3,8-diol(PMD) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Para-menthane-3,8-diol(PMD) for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs